Posted On:  November 2017

standard

How Women Like Susan McGalla are Taking Back Top Executive Roles

November 30, 2017 - By 

UPDATE: April 17th, 2020–

After serving on the board of HFS Inc for over 10 years until it was sold to JLL, Susan McGalla became a member of the Mcgee Women’s hospital executive committee, and in March of this year was named to the board of Francesca’s. read more


standard

Imran Haque And The Happenings With The Human Genome: CRISPR 2.0

November 29, 2017 - By 

Medical technology and practices have been advancing at an incredible rate over the past few decades, and one of the premier breakthroughs in the space is CRISPR. At a high level, CRISPR is a process that allows editing DNA sequences and gene function, which opens up a world of possibilities when it comes to developing new medicine and treatments. However, CRISPR as we know it today is not a perfectly precise tool, as it requires the rewrite of entire subsections of DNA or a genome. A new breakthrough in a joint study by Harvard and MIT has resulted in a new process called base editing, which gives researchers the ability to edit minute portions of DNA. In other words, if a single word needed changing in a paragraph, CRISPR would require rewriting the entire paragraph with one word changed while base editing would allow changing the specific word itself. read more


standard

CEO of LaunchPad Holdings, Glen Wakeman, Demands Amenable Clients to Trust Themselves

November 10, 2017 - By 
Glen Wakeman is inspiring entrepreneurs

**UPDATE** Glen Wakeman has released a new educational video that delivers crucial business advice for new businesses. He dives into the key factors needed to prevent your business from crashing. read more


standard

Eric Lefkofsky’s Trillion-Dollar Solution

November 6, 2017 - By 

“Let’s start with money,” says Eric Lefkofsky, in a recent blog post that was published in Crain’s Chicago Business. “We spend about $3 trillion a year on health care in this country,” and “roughly one-third is wasted.” The mission of his latest startup, Tempus, is to do what for healthcare that his other companies have done for marketing, transportation, and consumer goods. “By bringing Big Data (along with machine learning and artificial intelligence) to healthcare,” Mr. Lefkofsky believes, “we can reduce mortalities by well over 50 percent.” read more


Search

Blog Categories